These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 28073031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M, Jianghua W, Rujuan M, Wei Z, Qian W.
    J Neurol Sci; 2011 Jun 15; 305(1-2):92-6. PubMed ID: 21440911
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer's disease and dementia not due to Alzheimer's disease.
    Vogelgsang J, Shahpasand-Kroner H, Vogelgsang R, Streit F, Vukovich R, Wiltfang J.
    Exp Brain Res; 2018 May 15; 236(5):1241-1250. PubMed ID: 29480353
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
    Chatterjee P, Elmi M, Goozee K, Shah T, Sohrabi HR, Dias CB, Pedrini S, Shen K, Asih PR, Dave P, Taddei K, Vanderstichele H, Zetterberg H, Blennow K, Martins RN.
    J Alzheimers Dis; 2019 May 15; 71(3):775-783. PubMed ID: 31424403
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls.
    Feinkohl I, Schipke CG, Kruppa J, Menne F, Winterer G, Pischon T, Peters O.
    J Alzheimers Dis; 2020 May 15; 74(4):1285-1294. PubMed ID: 32176645
    [Abstract] [Full Text] [Related]

  • 9. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    Kim HJ, Park KW, Kim TE, Im JY, Shin HS, Kim S, Lee DH, Ye BS, Kim JH, Kim EJ, Park KH, Han HJ, Jeong JH, Choi SH, Park SA.
    J Alzheimers Dis; 2015 May 15; 48(4):1043-50. PubMed ID: 26444752
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Medical Histories of Control Subjects Influence the Biomarker Potential of Plasma Aβ in Alzheimer's Disease: a Meta-analysis.
    Zhang S, Huang SY, An XB, Zeng L, Ai J.
    J Mol Neurosci; 2020 Jun 15; 70(6):861-870. PubMed ID: 32125624
    [Abstract] [Full Text] [Related]

  • 12. Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer's disease: a cross-sectional analysis from the SILCODE study.
    Sheng C, Yang K, He B, Du W, Cai Y, Han Y.
    Alzheimers Res Ther; 2022 Feb 14; 14(1):35. PubMed ID: 35164860
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship Between Peripheral Transport Proteins and Plasma Amyloid-β in Patients with Alzheimer's Disease Were Different from Cognitively Normal Controls: A Propensity Score Matching Analysis.
    Gao L, Wang J, Jiang Y, Wei S, Shang S, Chen C, Dang L, Huo K, Deng M, Wang J, Qu Q.
    J Alzheimers Dis; 2020 Feb 14; 78(2):699-709. PubMed ID: 33016902
    [Abstract] [Full Text] [Related]

  • 16. Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's disease.
    Takeda S, Sato N, Uchio-Yamada K, Yu H, Moriguchi A, Rakugi H, Morishita R.
    Dement Geriatr Cogn Disord; 2012 Feb 14; 34(1):25-30. PubMed ID: 22889768
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study.
    Peters KE, Davis WA, Taddei K, Martins RN, Masters CL, Davis TM, Bruce DG.
    J Alzheimers Dis; 2017 Feb 14; 56(3):1127-1133. PubMed ID: 28106562
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.